Tirzepatide use is associated with a lower risk for CPAP use, hospitalization, and mortality in adults with obesity, T2D, and OSA.

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Mounjaro (tirzepatide) is a prescription drug for adults and certain children with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation ...

Findings showed 31.7% of patients receiving ixekizumab and tirzepatide achieved both ACR50 and at least 10% weight loss vs 0.8% on ixekizumab monotherapy. Topline data were announced from a phase 3b ...

Nutrition professionals are involved in few studies incorporating nutritional interventions or dietary assessments for patients receiving semaglutide or tirzepatide. HealthDay News — Nutritional ...

At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to ≥10% weight reduction with concomitant Taltz and ...

Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune disease characterised by loss of tolerance, widespread immune dysregulation, and production of diverse autoantibodies (typically ...

As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...